ATE303442T1 - Verbindungen aus moraxella catarrhalis - Google Patents
Verbindungen aus moraxella catarrhalisInfo
- Publication number
- ATE303442T1 ATE303442T1 AT99924948T AT99924948T ATE303442T1 AT E303442 T1 ATE303442 T1 AT E303442T1 AT 99924948 T AT99924948 T AT 99924948T AT 99924948 T AT99924948 T AT 99924948T AT E303442 T1 ATE303442 T1 AT E303442T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- moraxella catarrhalis
- polypeptides
- basb020
- prophylactic
- Prior art date
Links
- 241000588655 Moraxella catarrhalis Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810285.8A GB9810285D0 (en) | 1998-05-13 | 1998-05-13 | Novel compounds |
| PCT/EP1999/003257 WO1999058684A2 (en) | 1998-05-13 | 1999-05-07 | Compounds from moraxella catarrhalis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE303442T1 true ATE303442T1 (de) | 2005-09-15 |
Family
ID=10831997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99924948T ATE303442T1 (de) | 1998-05-13 | 1999-05-07 | Verbindungen aus moraxella catarrhalis |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7122197B1 (de) |
| EP (1) | EP1078064B1 (de) |
| JP (1) | JP4503175B2 (de) |
| KR (1) | KR100610448B1 (de) |
| CN (3) | CN100484956C (de) |
| AT (1) | ATE303442T1 (de) |
| AU (1) | AU737196B2 (de) |
| BR (1) | BR9911773A (de) |
| CA (1) | CA2328502A1 (de) |
| CZ (1) | CZ298227B6 (de) |
| DE (1) | DE69927017T2 (de) |
| DK (1) | DK1078064T3 (de) |
| ES (1) | ES2247803T3 (de) |
| GB (1) | GB9810285D0 (de) |
| HK (1) | HK1036299A1 (de) |
| HU (1) | HUP0102853A3 (de) |
| IL (2) | IL139612A0 (de) |
| NO (1) | NO330169B1 (de) |
| NZ (1) | NZ508322A (de) |
| PL (1) | PL199497B1 (de) |
| TR (1) | TR200003345T2 (de) |
| WO (1) | WO1999058684A2 (de) |
| ZA (1) | ZA200006522B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| WO2004015099A2 (en) | 2002-08-02 | 2004-02-19 | Glaxosmithkline Biologicals Sa | Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| CN111003884B (zh) * | 2019-12-05 | 2021-12-31 | 浙江海洋大学 | 重金属污水处理设备及处理方法 |
| CN114703214A (zh) * | 2022-03-03 | 2022-07-05 | 南京吉芮康生物科技研究院有限公司 | 一种抗丢失时空可控表达的新型质粒及其应用 |
| WO2024017827A1 (en) | 2022-07-19 | 2024-01-25 | Glaxosmithkline Biologicals Sa | Continuous process for vaccine production |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552146A (en) | 1991-08-15 | 1996-09-03 | Board Of Regents, The University Of Texas System | Methods and compositions relating to useful antigens of Moraxella catarrhalis |
| US5712118A (en) | 1993-09-29 | 1998-01-27 | Research Foundation Of State University Of New York | Vaccine for branhamella catarrhalis |
| US6440425B1 (en) | 1995-05-01 | 2002-08-27 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
| US6607731B1 (en) * | 1995-09-22 | 2003-08-19 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| US6090576A (en) * | 1996-03-08 | 2000-07-18 | Connaught Laboratories Limited | DNA encoding a transferrin receptor of Moraxella |
| US7341727B1 (en) | 1996-05-03 | 2008-03-11 | Emergent Product Development Gaithersburg Inc. | M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
| EP0920513A2 (de) | 1996-08-12 | 1999-06-09 | The Board Of Regents, The University Of Texas System | DEFINIERENDE ÄUSSERES MEMBRANPROTEIN CopB EPITOPEN VON MORAXELLA CATARRHALIS |
| US6673910B1 (en) | 1999-04-08 | 2004-01-06 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
| CA2378687A1 (en) | 1999-06-18 | 2000-12-28 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
-
1998
- 1998-05-13 GB GBGB9810285.8A patent/GB9810285D0/en not_active Ceased
-
1999
- 1999-05-07 PL PL344792A patent/PL199497B1/pl not_active IP Right Cessation
- 1999-05-07 US US09/700,228 patent/US7122197B1/en not_active Expired - Fee Related
- 1999-05-07 WO PCT/EP1999/003257 patent/WO1999058684A2/en active IP Right Grant
- 1999-05-07 KR KR1020007012705A patent/KR100610448B1/ko not_active IP Right Cessation
- 1999-05-07 CZ CZ20004203A patent/CZ298227B6/cs not_active IP Right Cessation
- 1999-05-07 DK DK99924948T patent/DK1078064T3/da active
- 1999-05-07 CN CNB2005100746588A patent/CN100484956C/zh not_active Expired - Fee Related
- 1999-05-07 BR BR9911773-8A patent/BR9911773A/pt not_active Application Discontinuation
- 1999-05-07 CN CNB998085545A patent/CN1210401C/zh not_active Expired - Fee Related
- 1999-05-07 EP EP99924948A patent/EP1078064B1/de not_active Expired - Lifetime
- 1999-05-07 AU AU41421/99A patent/AU737196B2/en not_active Ceased
- 1999-05-07 TR TR2000/03345T patent/TR200003345T2/xx unknown
- 1999-05-07 CN CNA2006100997400A patent/CN1876679A/zh active Pending
- 1999-05-07 JP JP2000548475A patent/JP4503175B2/ja not_active Expired - Fee Related
- 1999-05-07 IL IL13961299A patent/IL139612A0/xx active IP Right Grant
- 1999-05-07 HU HU0102853A patent/HUP0102853A3/hu unknown
- 1999-05-07 CA CA002328502A patent/CA2328502A1/en not_active Abandoned
- 1999-05-07 DE DE69927017T patent/DE69927017T2/de not_active Expired - Lifetime
- 1999-05-07 NZ NZ508322A patent/NZ508322A/xx unknown
- 1999-05-07 AT AT99924948T patent/ATE303442T1/de active
- 1999-05-07 ES ES99924948T patent/ES2247803T3/es not_active Expired - Lifetime
-
2000
- 2000-11-10 IL IL139612A patent/IL139612A/en not_active IP Right Cessation
- 2000-11-10 ZA ZA200006522A patent/ZA200006522B/en unknown
- 2000-11-10 NO NO20005697A patent/NO330169B1/no not_active IP Right Cessation
-
2001
- 2001-08-13 HK HK01105646A patent/HK1036299A1/xx not_active IP Right Cessation
-
2006
- 2006-02-28 US US11/364,212 patent/US20060147462A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE303442T1 (de) | Verbindungen aus moraxella catarrhalis | |
| ATE397666T1 (de) | Neue verbindungen aus moraxella catarrhalis | |
| DE69921649D1 (de) | Moraxella catarrhalis pilq proteine | |
| ATE312922T1 (de) | Moraxella catarrhalis polynukleotide und polypeptide | |
| PL345193A1 (en) | Basb027 proteins and genes from moraxella catarrhalis | |
| ATE454452T1 (de) | Basb118 polypeptid und polynukleotid aus moraxella catarrhalis | |
| DE69919693D1 (de) | Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis | |
| ATE360073T1 (de) | Basb119 polypeptid und polynukleotid aus moraxella catarrhalis | |
| DE60039303D1 (de) | Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen | |
| WO1999058682A3 (en) | Compounds from moraxella catarrhalis | |
| DE60019614D1 (de) | Moraxella catarrhalis antigen basb117 | |
| ATE368686T1 (de) | Polypeptide aus moraxella (branhamella) catarrhalis | |
| ATE293692T1 (de) | Moraxella catarrhalis antigen basb120 | |
| ATE311458T1 (de) | Basb111 polypeptid und polynukleotid aus moraxella catharralis | |
| WO2001009331A3 (en) | Moraxella catarrhalis antigen basb125 | |
| WO2001009330A3 (en) | Moraxella catarrhalis antigen basb121 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1078064 Country of ref document: EP |